{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:18:46Z","timestamp":1787735926531,"version":"build-2784847793"},"reference-count":20,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background\/Objectives: Congenital chylous ascites is a rare neonatal condition characterized by the accumulation of lymphatic fluid within the peritoneal cavity. The disorder can be difficult to manage, as many infants show limited response to standard conservative strategies such as dietary modification and supportive care. Currently, no universally accepted therapeutic guidelines exist. We report the successful use of propranolol in the management of refractory congenital chylous ascites. Methods: Clinical data were collected from a 35-week preterm male infant who had prenatal ultrasound evidence of fetal ascites from the 28th week of gestation. Postnatal management initially included fasting, total parenteral nutrition, and from day 9 of life, continuous infusion of octreotide. Due to the persistent ascites, oral propranolol was added to the therapy on the 31st day of life. Current literature was reviewed to compare our findings with those available. Results: Following the addition of propranolol to ongoing octreotide therapy, the infant demonstrated gradual clinical improvement with decreased abdominal distension and reduction of ascitic fluid; as propranolol and octreotide were administered concurrently for approximately 30 days, a causal effect could not be isolated to propranolol alone. Oral propranolol was administered at 0.5 mg\/kg every 6 h (2 mg\/kg\/day total), with heart rate, blood pressure, and glucose monitored throughout treatment; no propranolol-related adverse events (bradycardia, hypotension, bronchospasm, hypoglycemia, or feeding intolerance) occurred. Ultrasonographic resolution of ascites was achieved by day 48, the peritoneal drainage catheter having already been removed on day 34; propranolol was subsequently tapered and discontinued by day 68, and the patient was discharged in stable condition on day 93, with no recurrence on serial ultrasound over the 45 days from resolution to discharge. A narrative review of the literature identified nine infants with lymphatic disorders successfully treated with propranolol. Conclusions: This case suggests a possible temporal association between propranolol administration and clinical improvement in a neonate with congenital chylous ascites refractory to conventional management; no propranolol-related adverse events were observed during treatment. Given the rarity of this condition and the absence of standardized treatment guidelines, further studies\u2014potentially through multicenter registries or prospective case series\u2014are warranted to establish optimal dosing strategies, evaluate long-term outcomes, and clarify the role of propranolol in this setting.<\/jats:p>","DOI":"10.3390\/children13091141","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:15Z","timestamp":1787731875000},"page":"1141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Propranolol as Salvage Therapy for Refractory Congenital Chylous Ascites in a Preterm Neonate: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8023-167X","authenticated-orcid":false,"given":"Nicoletta","family":"Menzella","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Neonatal Intensive Care Unit, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d IRCCS, Largo Agostino Gemelli, 8, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Riitano","sequence":"additional","affiliation":[{"name":"Neonatology and Neonatal Intensive Care Unit, Policlinico Casilino, 00169 Rome, Italy"},{"name":"Neonatal Intensive Care Unit, Ospedale Policlinico Casilino, Via Casilina, 1049, 00169 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0980-5297","authenticated-orcid":false,"given":"Simonetta","family":"Costa","sequence":"additional","affiliation":[{"name":"Neonatology and Neonatal Intensive Care Unit, Policlinico Casilino, 00169 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Paola","family":"Fusco","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-2068","authenticated-orcid":false,"given":"Simona","family":"Fattore","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9191-4219","authenticated-orcid":false,"given":"Chiara","family":"Tirone","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-0708","authenticated-orcid":false,"given":"Francesca","family":"Stollagli","sequence":"additional","affiliation":[{"name":"Obstetrics and Obstetric Pathology Unit, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-9569","authenticated-orcid":false,"given":"Giovanni","family":"Vento","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Women and Child Health Sciences, Child Health Area, Universit\u00e0 Cattolica Del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MOP.0000000000001109","article-title":"Neonatal lymphatic flow disorders: Central lymphatic flow disorder and isolated chylothorax, diagnosis and treatment using novel lymphatic imaging and interventions technique","volume":"34","author":"Rabinowitz","year":"2022","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/ppul.25601","article-title":"Chylothorax in the neonate\u2014A stepwise approach algorithm","volume":"56","author":"Rocha","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2458\/lymph.5404","article-title":"Chylous ascites in the neonate: A narrative review","volume":"55","author":"Rocha","year":"2022","journal-title":"Lymphology"},{"key":"ref_4","first-page":"58","article-title":"Congenital chylous ascites","volume":"76","author":"Wawrzoniak","year":"2011","journal-title":"Pol. J. Radiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e235849","DOI":"10.1136\/bcr-2020-235849","article-title":"Management of large congenital chylous ascites in a preterm infant: Fetal and neonatal interventions","volume":"13","author":"Sooklin","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000518217","article-title":"Congenital chylothorax of the newborn: A systematic analysis of published cases between 1990 and 2018","volume":"101","author":"Resch","year":"2022","journal-title":"Respiration"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF00975679","article-title":"Lymphatic abnormalities in Noonan\u2019s syndrome","volume":"7","author":"Lanning","year":"1978","journal-title":"Pediatr. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e7594","DOI":"10.1097\/MD.0000000000007594","article-title":"Effects of somatostatin\/octreotide treatment in neonates with congenital chylothorax","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine"},{"key":"ref_9","first-page":"447","article-title":"Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders: A case series","volume":"27","author":"Serio","year":"2022","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_10","first-page":"155","article-title":"Propranolol for the treatment of lymphatic malformations in a neonate\u2014A case report and review of literature","volume":"25","author":"Liviskie","year":"2020","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2020049699","DOI":"10.1542\/peds.2020-049699","article-title":"Use of propranolol in the treatment of chylous effusions in infants","volume":"148","author":"Mitchell","year":"2021","journal-title":"Pediatrics"},{"key":"ref_12","first-page":"468","article-title":"Propranolol as a treatment option for chylous effusions and chylous ascites in fetuses and neonates: A systematic review","volume":"29","author":"Courteau","year":"2024","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2022058555","DOI":"10.1542\/peds.2022-058555","article-title":"Propranolol therapy for congenital chylothorax","volume":"151","author":"Midura","year":"2023","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"bcr2012006196","DOI":"10.1136\/bcr-2012-006196","article-title":"Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn","volume":"2012","author":"Olivieri","year":"2012","journal-title":"BMJ Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00246-019-02230-z","article-title":"ChyloBEST: Chylothorax in infants and nutrition with low-fat breast milk","volume":"41","author":"Neumann","year":"2020","journal-title":"Pediatr. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"De Rose, D.U., Landolfo, F., Pugnaloni, F., Gassabi, F.Z., Martini, L., Santisi, A., Columbo, C., Giliberti, P., Gazzotti, F., and Porzio, O. (2025). Lymphocytes and immunoglobulins in peripheral blood and lymphatic fluid of neonates with chylothorax. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1666366"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1651-2227.2010.01818.x","article-title":"Therapeutic management of neonatal chylous ascites: Report of a case and review of the literature","volume":"99","author":"Karagol","year":"2010","journal-title":"Acta Paediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1651-2227.2004.tb02944.x","article-title":"Intractable congenital chylous ascites","volume":"93","author":"Stokkel","year":"2004","journal-title":"Acta Paediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/jpc.13889","article-title":"Octreotide for congenital and acquired chylothorax in newborns: A systematic review","volume":"54","author":"Bellini","year":"2018","journal-title":"J. Paediatr. Child Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12098-010-0256-1","article-title":"Successful management of congenital chylous ascites in a premature infant using somatostatin analogue","volume":"78","author":"Huang","year":"2011","journal-title":"Indian J. Pediatr."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:35:07Z","timestamp":1787733307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["children13091141"],"URL":"https:\/\/doi.org\/10.3390\/children13091141","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}